Century Therapeutics's workforce strategy from 2020 to 2026 has been characterized by a pronounced trend of strategic contraction and operational streamlining. A significant pivot occurred in early 2023, marked by the layoff of approximately 25% of its total workforce and the concurrent closure of its Seattle hub. These substantial reductions were explicitly undertaken to financially sustain the company and reflected a broader de-prioritization of certain programs within its portfolio. This strategic recalibration underscores a clear mandate for capital preservation and a sharpened focus on core initiatives. The pattern of workforce optimization continued into 2025, with a further 72 employees impacted by layoffs in Pennsylvania on August 1st, as detailed in a WARN filing. This most recent action reinforces the company's sustained commitment to a leaner operational footprint, indicating an ongoing emphasis on efficiency and resource allocation in a challenging biotech landscape.